title: Treatment with 1,25(QH)2D3 in predialysis chronic renal failure.
authors.affiliation: Chair of Nephrology, 'La Sapienza' University, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Coen
authors.forename: S
authors.initials: S
authors.lastname: Mazzaferro
authors.forename: P
authors.initials: P
authors.lastname: Ballanti
authors.forename: S
authors.initials: S
authors.lastname: Costantini
authors.forename: E
authors.initials: E
authors.lastname: Bonucci
authors.forename: F
authors.initials: F
authors.lastname: Bondatti
authors.forename: M
authors.initials: M
authors.lastname: Manni
authors.forename: M
authors.initials: M
authors.lastname: Pasquali
authors.forename: D
authors.initials: D
authors.lastname: Sardella
authors.forename: F
authors.initials: F
authors.lastname: Taggi
mesh_terms: D000328:Adult; D000535:Aluminum / Q000032:analysis; D001842:Bone and Bones / Q000737:chemistry / Q000473:pathology; D002117:Calcitriol / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D003404:Creatinine; D000535:Aluminum; D002117:Calcitriol